271 related articles for article (PubMed ID: 32548126)
1. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
[TBL] [Abstract][Full Text] [Related]
2. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
3. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles.
Aya-Bonilla C; Gray ES; Manikandan J; Freeman JB; Zaenker P; Reid AL; Khattak MA; Frank MH; Millward M; Ziman M
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30769764
[TBL] [Abstract][Full Text] [Related]
5. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.
Rapanotti MC; Campione E; Spallone G; Orlandi A; Bernardini S; Bianchi L
Cell Death Discov; 2017; 3():17005. PubMed ID: 28280601
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.
Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
[TBL] [Abstract][Full Text] [Related]
8. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
9. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.
Freeman JB; Gray ES; Millward M; Pearce R; Ziman M
J Transl Med; 2012 Sep; 10():192. PubMed ID: 22978632
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
12. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
13. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
14. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
15. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.
Reid AL; Millward M; Pearce R; Lee M; Frank MH; Ireland A; Monshizadeh L; Rai T; Heenan P; Medic S; Kumarasinghe P; Ziman M
Br J Dermatol; 2013 Jan; 168(1):85-92. PubMed ID: 23013138
[TBL] [Abstract][Full Text] [Related]
16. Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis.
Tucci M; D'Oronzo S; Mannavola F; Felici C; Lovero D; Cafforio P; Palmirotta R; Silvestris F
Ther Adv Med Oncol; 2020; 12():1758835920905415. PubMed ID: 32206092
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Circulating Melanoma Cells.
Ma J; Frank MH
Methods Mol Biol; 2015 Sep; ():. PubMed ID: 26415609
[TBL] [Abstract][Full Text] [Related]
18. Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.
Gray ES; Reid AL; Bowyer S; Calapre L; Siew K; Pearce R; Cowell L; Frank MH; Millward M; Ziman M
J Invest Dermatol; 2015 Aug; 135(8):2040-2048. PubMed ID: 25830652
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
Pang Y; Maxwell E; Sindrewicz-Goral P; Shapanis A; Li S; Morgan M; Yu LG
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291660
[TBL] [Abstract][Full Text] [Related]
20. Cellular adhesion pathways and metastatic potential of human melanoma.
McGary EC; Lev DC; Bar-Eli M
Cancer Biol Ther; 2002; 1(5):459-65. PubMed ID: 12496470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]